CG Oncology

Cold Genesys is a private clinical-stage biopharmaceutical company dedicated to the research and development of novel immunotherapies. It focuses on developing oncolytic immunotherapies for cancer treatment, providing patients with new and impactful therapeutic options. Oncolytic immunotherapy is a form of cancer treatment that utilizes genetically modified viruses to preferentially kill cancer cells and elicit an anti-tumor immune response. Our product CG0070 is at the forefront of this field, leading a two-pronged attack on cancer through both direct and indirect mechanisms.